Skip to content

Clinical trials

Major Depressive Disorder trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Belgium Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20062
20074
20081
20101
20113
20123
20131
20151
20173
20182
20193
20205
20212
20222
20232
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated5
Recruiting4
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC11
University Hospital, Ghent4
AstraZeneca3
Eli Lilly and Company3
GlaxoSmithKline3
H. Lundbeck A/S2
Janssen-Cilag International NV2
Neurocrine Biosciences2
Sanofi2
Universitaire Ziekenhuizen KU Leuven2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder46
Depressive Disorder5
Depressive Disorder, Treatment-Resistant5
Anhedonia3
Mood Disorders2
Alzheimer Disease1
Anxiety Disorders1
Bipolar Disorder1
Brain Diseases1
COVID-191

Trials

Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.